Dean J. Naylor

Corporate Officer/Principal at The University of Queensland

Consumer Services

Health Technology

Profile

Dean J.
Naylor is currently a Principal at The University of Queensland.
Prior to this, he was a Principal at the University of Adelaide and Head-Intellectual Property Development at CBio Ltd.

Dean J. Naylor active positions

Companies	Position	Start
The University of Queensland	Corporate Officer/Principal	-

All active positions of Dean J. Naylor

Former positions of Dean J. Naylor

Companies	Position	End
University of Adelaide	Corporate Officer/Principal	-
CBio Ltd. CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.	Corporate Officer/Principal	-

See the detail of Dean J. Naylor's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dean J. Naylor's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
CBio Ltd. CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.	Health Technology